[Federal Register Volume 67, Number 230 (Friday, November 29, 2002)]
[Notices]
[Page 71184]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-30240]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, HLA Typing and Epitope Mapping 
Relative to HIV Vaccine Design.
    Date: December 11, 2002.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: NIAID, DEA, SRP, 6700B Rockledge Drive, Rm. 2148A, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Katherine L. White, PhD, Scientific Review 
Administrator, AIDS Preclinical Research Review Branch, Scientific 
Review Program, National Institutes of Allergy and Infectious 
Diseases, Room 3119, Bethesda, MD 20892, (301) 435-1615, 
[email protected]


(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 21, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-30240 Filed 11-27-02; 8:45 am]
BILLING CODE 4140-01-M